Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhongbao Pharmaceutical is a comprehensive pharmaceutical enterprise based in Taizhou, China, primarily focused on the production of large-volume and small-volume parenteral injections. The company maintains a robust portfolio of generic medications covering therapeutic areas such as anti-infectives, cardiovascular health, and electrolyte replacement. With advanced GMP-certified manufacturing facilities, it produces a variety of delivery formats including glass bottles, soft bags, and plastic bottles. Zhejiang Zhongbao Pharmaceutical serves as a significant supplier in the Chinese domestic market while also pursuing international export opportunities for its essential medicine products. Its research and development efforts are centered on improving drug delivery systems and expanding its range of high-quality generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Zhongbao Pharmaceutical.